Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act]: Analytik Jena AG Acquires US Company UVP, LLC

Jena (Germany), April 2, 2013 - Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) has with the approval of the Supervisory Board today signed a contract for the acquisition of all shares of UVP, LLC, incorporated under US law as a limited liability company, based in Upland/California, USA. Upon the transfer of the shares for purposes of the closing of this transaction, which is scheduled for April 5, 2013, Analytik Jena AG acquires besides the UVP, LLC also its wholly owned subsidiary, Ultra-Violet Products Ltd., based in Cambridge, Great Britain. The parties have agreed not to reveal the purchase price.

UVP, LLC is a globally-operating provider of predominantly digital imaging systems for applications in proteomics, genomics and plant and animal sciences. The UVP group generated sales of around USD 17.2 m in the past financial year 2012 and has 109 employees worldwide. Almost half of the sales are generated in North America. The company operates its business already since 1932.

By integrating UVP, LLC into the Analytik Jena Group a significant increase of the revenue and earnings figures of the Life Science business unit as well as numerous synergies are expected. The Company aims to reach an operating result (EBIT) above breakeven in this unit already for the 2nd half of financial year 2012/2013 and expects for the financial year 2013/2014 (which begins in October) sales above EUR 40.0 m and operating earnings of 4.0 % to 7.0 %. Alongside the expansion and rounding off of the product portfolio, Analytik Jena plans with this acquisition to enter the US market with the products of the Life Science business unit.